Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01842815 · ClinicalTrials.gov registry record · NA

Evaluation of the 755nm Alexandrite for Unwanted Tattoos

A NA study, sponsored by Cynosure.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01842815: Completed NA study, sponsored by Cynosure.

NCT01842815 is a NA study that has completed, run by Cynosure. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01842815, a NA study, has completed, sponsored by Cynosure.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using a 755nm Alexandrite laser.

Primary Outcome

Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0 to 10, where 0 is 0% tattoo cleared compared to the baseline tattoo, and 10 is 100% of tattoo cleared compared to the baseline tattoo.

Interventions

  • DEVICE 755 nm alexandrite laser

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-03
Est. Completion 2015-12
Phase NA
Cynosure

49 total trials

What the finished NCT01842815 record still lists

NCT01842815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which 755 nm alexandrite laser is the first listed.

NCT01842815 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01842815 about?

NCT01842815 is a clinical study titled "Evaluation of the 755nm Alexandrite for Unwanted Tattoos". The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using a 755nm Alexandrite laser.

What is the current status of trial NCT01842815?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-03. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01842815?

The interventions under investigation include: 755 nm alexandrite laser (DEVICE).

Who is sponsoring clinical trial NCT01842815?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01842815's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01842815, the US trial registry maintained by the National Library of Medicine. NCT01842815 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.